Bayer Sets Out Improved Sales, Profitability Forecasts
FRANKFURT—German pharmaceuticals and chemicals group Bayer AG said Tuesday it is targeting increased sales and earnings growth over the next few years at its drug and crop-science businesses, just days after announcing a planned $ 66 billion takeover of U.S. seed company Monsanto Co. “We are optimistic about Bayer’s medium-term development and have… Read More »